Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1678
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2490
    -0.0021 (-0.17%)
     
  • Bitcoin GBP

    51,153.00
    -603.11 (-1.17%)
     
  • CMC Crypto 200

    1,327.17
    -69.37 (-4.77%)
     
  • S&P 500

    5,109.49
    +61.07 (+1.21%)
     
  • DOW

    38,297.67
    +211.87 (+0.56%)
     
  • CRUDE OIL

    83.82
    +0.25 (+0.30%)
     
  • GOLD FUTURES

    2,346.40
    +3.90 (+0.17%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

What Is Calpine Corporation’s (CPN) Share Price Doing?

Calpine Corporation (NYSE:CPN), a utilities company based in United States, saw a decent share price growth in the teens level on the NYSE over the last few months. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Today I will analyse the most recent data on CPN’s outlook and valuation to see if the opportunity still exists. View our latest analysis for Calpine

What's the opportunity in CPN?

Great news for investors – CPN is still trading at a fairly cheap price. My valuation model shows that the stock’s value should be $23.55 but it is currently trading at $14.7 on the share market, meaning that there is still an opportunity to buy now. Although, there may be another chance to buy again in the future. This is because CPN’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, CPN’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What does the future of CPN look like?

NYSE:CPN Future Profit Sep 16th 17
NYSE:CPN Future Profit Sep 16th 17

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio.Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to more than double over the next couple of years, the future seems bright for CPN. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? Since CPN is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on CPN for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy CPN. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Calpine. You can find everything you need to know about CPN in the latest infographic research report. If you are no longer interested in Calpine, you can use our free platform to see my list of over 50 other stocks with a high growth potential.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.